Skip to main content
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India flag India · Delayed Price · Currency is INR
208.83
+3.28 (1.60%)
Apr 29, 2026, 3:29 PM IST

Jagsonpal Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Jagsonpal Pharmaceuticals had annual revenue of 2.99B INR with 11.35% growth. Jagsonpal Pharmaceuticals had revenue of 761.98M in the quarter ending March 31, 2026, with 30.12% growth.

Revenue
2.99B
Revenue Growth
+11.35%
P/S Ratio
4.61
Revenue / Employee
2.14M
Employees
1,399
Market Cap
13.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20262.99B305.04M11.35%
Mar 31, 20252.69B600.14M28.76%
Mar 31, 20242.09B-280.12M-11.83%
Mar 31, 20232.37B191.30M8.79%
Mar 31, 20222.18B296.38M15.77%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Beta Drugs 3.85B
Sakar Healthcare 2.31B
Ind-Swift Laboratories 5.94B
Windlas Biotech 8.68B
Indoco Remedies 17.60B
Sigachi Industries 4.85B
Solara Active Pharma Sciences 12.55B
Orchid Pharma 8.11B
Revenue Rankings

Jagsonpal Pharmaceuticals News

More News